Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches.

RECENT NEWS

May 3, 2018 Vical Reports First Quarter 2018 Financial and Operational Results
April 26, 2018 Vical Announces News Release and Conference Call Schedule for First Quarter 2018 Financial Results

May 3, 2018
Vical Reports First Quarter 2018 Financial and Operational Results

April 26, 2018
Vical Announces News Release and Conference Call Schedule for First Quarter 2018 Financial Results

EVENTS & PRESENTATIONS

May 3, 2018 Vical Incorporated 1Q18 Financial Results Conference Call View the Webcast
March 15, 2018 Vical Incorporated 4Q17 Financial Results Conference Call View the Webcast

May 3, 2018
Vical Incorporated 1Q18 Financial Results Conference Call

March 15, 2018
Vical Incorporated 4Q17 Financial Results Conference Call

PRODUCT PIPELINE

CONNECT WITH US

RSS Feeds
Email Alerts
LinkedIn
Slideshare
StockTwits
Twitter
YouTube

Privacy Policy
Terms of Use
Site Map

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121

This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.